Citigroup’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.82K | Sell |
4,718
-4,582
| -49% | -$3.71K | ﹤0.01% | 4565 |
|
|
2025
Q1 | $7.14K | Sell |
9,300
-915
| -9% | -$703 | ﹤0.01% | 4464 |
|
|
2024
Q4 | $13K | Buy |
10,215
+560
| +6% | +$714 | ﹤0.01% | 4483 |
|
|
2024
Q3 | $20K | Buy |
9,655
+6,641
| +220% | +$13.7K | ﹤0.01% | 4399 |
|
|
2024
Q2 | $11.5K | Buy |
3,014
+205
| +7% | +$781 | ﹤0.01% | 4368 |
|
|
2024
Q1 | $13.3K | Buy |
2,809
+682
| +32% | +$3.23K | ﹤0.01% | 4377 |
|
|
2023
Q4 | $9.08K | Buy |
2,127
+1,601
| +304% | +$6.84K | ﹤0.01% | 4453 |
|
|
2023
Q3 | $1.63K | Sell |
526
-3,315
| -86% | -$10.2K | ﹤0.01% | 4257 |
|
|
2023
Q2 | $17.3K | Sell |
3,841
-66,926
| -95% | -$301K | ﹤0.01% | 4302 |
|
|
2023
Q1 | $403K | Buy |
70,767
+10,695
| +18% | +$61K | ﹤0.01% | 2674 |
|
|
2022
Q4 | $363K | Buy |
60,072
+51,540
| +604% | +$311K | ﹤0.01% | 2720 |
|
|
2022
Q3 | $56K | Buy |
8,532
+7,691
| +915% | +$50.5K | ﹤0.01% | 3632 |
|
|
2022
Q2 | $4K | Sell |
841
-878
| -51% | -$4.18K | ﹤0.01% | 4924 |
|
|
2022
Q1 | $12K | Sell |
1,719
-2,359
| -58% | -$16.5K | ﹤0.01% | 4660 |
|
|
2021
Q4 | $51K | Sell |
4,078
-20,190
| -83% | -$252K | ﹤0.01% | 4293 |
|
|
2021
Q3 | $758K | Sell |
24,268
-51,355
| -68% | -$1.6M | ﹤0.01% | 2599 |
|
|
2021
Q2 | $2.17M | Buy |
75,623
+15,026
| +25% | +$430K | ﹤0.01% | 2043 |
|
|
2021
Q1 | $2.63M | Buy |
60,597
+58,866
| +3,401% | +$2.55M | ﹤0.01% | 1769 |
|
|
2020
Q4 | $124K | Buy |
+1,731
| New | +$124K | ﹤0.01% | 3543 |
|